DTIL - Precision BioSciences, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
189,576
143,663
89,798
180,886
Total cash
189,576
143,663
89,798
180,886
Net receivables
720
488
10,000
965
Other current assets
1,257
169
4
2,324
Total current assets
199,105
161,754
105,564
193,672
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
54,252
53,248
60,578
50,220
Accumulated depreciation
-31,088
-23,914
-19,078
-10,649
Net property, plant and equipment
23,164
29,334
41,500
39,571
Equity and other investments
4,748
6,842
-
-
Intangible assets
1,348
2,048
1,373
1,432
Other long-term assets
2,570
4,641
1,721
558
Total non-current assets
39,064
49,744
44,594
41,561
Total assets
238,169
211,498
150,158
235,233
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,225
1,144
792
2,037
Accrued liabilities
3,206
4,028
3,269
2,400
Deferred revenues
46,192
21,244
30,236
16,486
Other current liabilities
745
977
854
1,584
Total current liabilities
59,664
35,980
42,829
26,932
Non-current liabilities
Long-term debt
22,223
2,478
-
-
Deferred revenues
92,872
77,015
53,926
65,895
Other long-term liabilities
201
44
392
-
Total non-current liabilities
118,072
84,350
62,904
69,987
Total liabilities
177,736
120,330
105,733
96,919
Stockholders' equity
Common stock
1
0
0
0
Retained earnings
-428,312
-316,675
-286,073
-177,067
Total stockholders' equity
60,433
91,168
44,425
138,314
Total liabilities and stockholders' equity
238,169
211,498
150,158
235,233